Consti delivered a strong ending to 2020, with resilient revenue and order intake. Margin
delivery was again precise. With the help of strong cash flow, we believe Consti has
derisked already ahead of the arbitration decision, as net debt to EBITDA has declined
to 0.6x. We raise our fair valuation range to EUR12-14.